These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686 [TBL] [Abstract][Full Text] [Related]
43. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research. Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974 [TBL] [Abstract][Full Text] [Related]
44. Modeling Alzheimer's disease in transgenic mice. Duff K J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589 [TBL] [Abstract][Full Text] [Related]
45. Alzheimer's disease: Abeta, tau and synaptic dysfunction. LaFerla FM; Oddo S Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755 [TBL] [Abstract][Full Text] [Related]
46. Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Götz J; Streffer JR; David D; Schild A; Hoerndli F; Pennanen L; Kurosinski P; Chen F Mol Psychiatry; 2004 Jul; 9(7):664-83. PubMed ID: 15052274 [TBL] [Abstract][Full Text] [Related]
47. Transgenic mouse models of Alzheimer's disease: phenotype and application. Higgins GA; Jacobsen H Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255 [TBL] [Abstract][Full Text] [Related]
48. Transgenic mouse and chemical lesion approaches to the study of Alzheimer's disease. Tang F; Li H; Nag S; Xu G; Chan T Chin Med J (Engl); 1997 Aug; 110(8):642-7. PubMed ID: 9594272 [No Abstract] [Full Text] [Related]
49. A decade of modeling Alzheimer's disease in transgenic mice. McGowan E; Eriksen J; Hutton M Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017 [TBL] [Abstract][Full Text] [Related]
50. Role of apoE/Abeta interactions in Alzheimer's disease: insights from transgenic mouse models. Brendza RP; Bales KR; Paul SM; Holtzman DM Mol Psychiatry; 2002; 7(2):132-5. PubMed ID: 11840304 [No Abstract] [Full Text] [Related]
51. Steps towards a mouse model of Alzheimer's disease. Crowther RA Bioessays; 1995 Jul; 17(7):593-5. PubMed ID: 7646481 [TBL] [Abstract][Full Text] [Related]
52. Altered synaptic function in Alzheimer's disease. Bell KF; Claudio Cuello A Eur J Pharmacol; 2006 Sep; 545(1):11-21. PubMed ID: 16887118 [TBL] [Abstract][Full Text] [Related]